)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Glaukos
Glaukos (GKOS) investor relations material
Glaukos 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary14 Jan, 2026
Business innovation and product development
Focus on innovation has led to leadership in MIGS and creation of new markets in ophthalmology, including procedural pharmaceuticals and corneal cross-linking.
Over $800 million invested in R&D since 2018, resulting in 12 commercial products and 13 in development.
Platforms like iStent, iDose, iLink, and iLution drive cascades of new products and address unmet clinical needs.
Sustained over 20% CAGR for 10 years, with a record quarter and 30% market growth recently.
Expansion into rare diseases and transdermal therapies, with plans to build a retinal company.
Glaucoma treatment paradigm and product pipeline
Current glaucoma treatment is seen as outdated; focus is on interventional approaches for better adherence and outcomes.
iDose TR offers sustained intraocular pressure reduction, with 81% of patients off all medications at one year and 70% well controlled at three years.
New products like iDose Trio and iDose TREX aim to extend duration and facilitate in-office use, with clinical trials underway.
iStent infinite demonstrated superior safety and efficacy in trials, with plans to expand indications by 2027.
Market opportunity includes 12 million diagnosed eyes, with potential for multiple interventions per patient over 20 years.
Commercial strategy and market expansion
Combination therapy (iDose with iStent) is being studied for additive effects.
In-office injectable therapy and repeat administration approvals are expected to drive adoption.
Vision for 2035 includes as many interventional glaucoma procedures as cataract surgeries.
Full product portfolio covers all stages of glaucoma, aiming for best benefit-to-risk ratio.
What specific FDA feedback boosts iDose PDUFA confidence?
What is the biggest hurdle for Epioxa payer access?
Confirm iDose underlying Q4 run rate for 2026 base?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Glaukos earnings date
Q4 202517 Feb, 2026
Glaukos
Next Glaukos earnings date
Q4 202517 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Glaukos Corporation develops and commercializes medical devices and pharmaceuticals for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is known for its minimally invasive surgical technologies and ophthalmic drug delivery platforms. The company is headquartered in Aliso Viejo, California, and its shares are listed on the NYSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage